ABM Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

ABM Industries is set to release its Q2 earnings before market open on Friday, with analysts anticipating EPS of $0.86, slightly down from $0.87 year-over-year, and revenue of $2.06 billion, up from $2.02 billion. The company's Q1 sales beat estimates, growing 2.2% to $2.11 billion. Recent analyst ratings show mixed sentiment, with UBS downgrading its price target to $50 while Truist Securities and Baird raised their price targets to $55 and $56, respectively, maintaining hold/neutral ratings.

Analysis

ABM Industries is scheduled to release its second-quarter financial results before market open on June 6. Analysts anticipate quarterly earnings of $0.86 per share, a marginal decrease from $0.87 per share in the year-ago period, while revenue is projected to increase to $2.06 billion from $2.02 billion. This follows a first quarter where ABM's sales grew 2.2% year-over-year to $2.11 billion, exceeding the consensus estimate of $2.09 billion. Despite this Q1 revenue outperformance, shares of ABM recently fell 2.1% to $51.26 on Thursday, reflecting some investor apprehension ahead of the Q2 report, particularly concerning the forecasted EPS dip. Recent analyst actions show a mixed to neutral stance: UBS analyst Joshua Chan maintained a Neutral rating and cut the price target from $56 to $50 on March 13, 2025, as reported in the article. Conversely, Truist Securities analyst Jasper Bibb maintained a Hold rating and increased the price target from $49 to $55 on September 9, 2024, while Baird analyst Andrew Wittmann maintained a Neutral rating and raised the price target from $49 to $56 on September 9, 2024. The overall sentiment signal is mixed (0.0 score) with a low-to-moderate market impact score (0.3), underscoring the importance of the upcoming earnings for clarifying ABM's profitability trajectory and justifying valuations within the $50-$56 analyst target range.

Key Decisions for Investors

• Investors should closely examine ABM's Q2 earnings on June 6, particularly the reported EPS versus the $0.86 forecast and any management commentary on factors impacting profitability, given the expected year-over-year earnings per share decline.
• Given the mixed analyst signals—Neutral/Hold ratings with UBS cutting its price target to $50 (on March 13, 2025, per the article) while Truist and Baird raised targets to $55-$56 (on Sept. 9, 2024, per the article)—it may be prudent to assess the Q2 results and updated company outlook before making significant portfolio adjustments, especially considering the recent 2.1% share price drop.
• Prospective investors might consider the current share price of $51.26 relative to the diverse analyst price targets ($50-$56) and await the Q2 earnings release to gauge the company's ability to achieve its $2.06 billion revenue target and navigate margin pressures before initiating a position.